These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24. [Multiple myeloma and the kidneys]. Kamaeva OI Ter Arkh; 1997; 69(6):73-5. PubMed ID: 9297284 [No Abstract] [Full Text] [Related]
25. Plasma cell neoplasms. Review of disease progression and report of a new variant. Nolan KD; Mone MC; Nelson EW Surg Oncol; 2005 Aug; 14(2):85-90. PubMed ID: 15993050 [TBL] [Abstract][Full Text] [Related]
26. Multiple myeloma--an update on diagnosis and treatment. Caers J; Vande broek I; De Raeve H; Michaux L; Trullemans F; Schots R; Van Camp B; Vanderkerken K Eur J Haematol; 2008 Nov; 81(5):329-43. PubMed ID: 18637123 [TBL] [Abstract][Full Text] [Related]
27. [Activin A induces apoptotic cell death of myeloma cells]. Yamato K; Koseki T; Kisaki M; Ikeda Y; Nishihara T Rinsho Ketsueki; 1996 Jul; 37(7):564-73. PubMed ID: 8779773 [No Abstract] [Full Text] [Related]
28. Case report of multiple myeloma and hypothyroidism in primary biliary cirrhosis. Rodríguez-Leal GA; Moran-Villota S; Arista-Nasr J; Uribe-Esquivel M Rev Invest Clin; 1997; 49(3):215-20. PubMed ID: 9294961 [TBL] [Abstract][Full Text] [Related]
29. Association of chronic lymphocytic leukaemia and multiple myeloma: report of a case and review of the literature. Quaglino D; Paterlini P; De Pasquale A; Cretara G; Venturoni L Haematologica; 1982 Aug; 67(4):576-88. PubMed ID: 6815016 [No Abstract] [Full Text] [Related]
30. The role of the bone marrow microenvironment in the pathophysiology of myeloma and its significance in the development of more effective therapies. Mitsiades CS; McMillin DW; Klippel S; Hideshima T; Chauhan D; Richardson PG; Munshi NC; Anderson KC Hematol Oncol Clin North Am; 2007 Dec; 21(6):1007-34, vii-viii. PubMed ID: 17996586 [TBL] [Abstract][Full Text] [Related]
35. Using genomics to identify high-risk myeloma after autologous stem cell transplantation. Shaughnessy JD; Barlogie B Biol Blood Marrow Transplant; 2006 Jan; 12(1 Suppl 1):77-80. PubMed ID: 16399589 [TBL] [Abstract][Full Text] [Related]
36. [Renal insufficiency due to light chain multiple myeloma]. van Zaanen HC; Diderich PP; Pegels JG; Ruizeveld de Winter JA Ned Tijdschr Geneeskd; 2000 Nov; 144(45):2133-7. PubMed ID: 11086485 [TBL] [Abstract][Full Text] [Related]
37. Multiple myeloma: the number of reinfused plasma cells does not influence outcome of patients treated with intensified chemotherapy and PBPC support. Boccadoro M; Omedé P; Dominietto A; Palumbo A; Bringhen S; Giaretta F; Ortolano B; Triolo S; Pileri A Bone Marrow Transplant; 2000 Jan; 25(1):25-9. PubMed ID: 10654010 [TBL] [Abstract][Full Text] [Related]
38. Cytological and histological classification of multiple myeloma. Wutke K; Várbíró M; Rüdiger KD; Kelényi G Haematologia (Budap); 1981; 14(3):315-29. PubMed ID: 7327443 [TBL] [Abstract][Full Text] [Related]
39. Regulation of Bcl-2-family proteins in myeloma cells by three myeloma survival factors: interleukin-6, interferon-alpha and insulin-like growth factor 1. Jourdan M; De Vos J; Mechti N; Klein B Cell Death Differ; 2000 Dec; 7(12):1244-52. PubMed ID: 11175262 [TBL] [Abstract][Full Text] [Related]